|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 21-01-19 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 20-12-22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 2019-12-31 |
Patty Meehan
ADM | Chief Administrative Officer | - | 2001-12-31 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kyle C. Kerbawy
CHM | Chairman | 79 | 2015-07-31 |
Sally L. Maher
BRD | Director/Board Member | - | 2019-04-30 |
| Director/Board Member | 71 | 2019-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 340M | |
| -0.31% | -1.94% | -24.39% | +2.91% | 175B | |
| +0.97% | -2.45% | -5.01% | +13.74% | 114B | |
| -1.01% | -4.01% | -1.04% | +66.14% | 57.98B | |
| +0.01% | +1.73% | -0.42% | -30.03% | 50.07B | |
| -1.00% | +0.37% | +14.24% | +51.55% | 50.13B | |
| +0.07% | -2.79% | +29.18% | -9.20% | 32.71B | |
| +1.07% | +9.73% | - | - | 30.77B | |
| +1.41% | +3.83% | +43.64% | -0.90% | 26.44B | |
| +1.48% | +6.49% | +28.50% | -2.74% | 23.96B | |
| Average | +0.24% | +1.43% | +10.59% | +11.43% | 56.16B | |
| Weighted average by Cap. | +0.13% | -0.18% | -2.66% | +12.45% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 89.22M 78.47M 74.2M 67.3M 126M 8.56B 127M 888M 343M 4.37B 335M 328M 14.04B | 101M 88.65M 83.83M 76.03M 143M 9.68B 144M 1B 388M 4.94B 378M 370M 15.87B |
| Net income | -3.13M -2.75M -2.6M -2.36M -4.44M -301M -4.46M -31.18M -12.04M -153M -11.76M -11.5M -493M | 1.45M 1.27M 1.2M 1.09M 2.05M 139M 2.06M 14.43M 5.57M 70.96M 5.44M 5.32M 228M |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
